Jonathan Parker
- Co-authors
- John DarmawanPeter J.F. SnijdersJ. M. M. WalboomersRenske D.M. SteenbergenLouise T. ChowChris J.L.M. MeijerThomas R. BrokerRichard J. Whitley
- Topics
- Virus-based gene therapy research (3 papers)Herpesvirus Infections and Treatments (3 papers)Vascular Tumors and Angiosarcomas (1 paper)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Jonathan Parker
11 papers receiving 319 citations
Peers
Comparison fields: 5 of 67
- Epidemiology 130
- Molecular Biology 87
- Rheumatology 67
- Genetics 66
- Immunology 60
Countries citing papers authored by Jonathan Parker
This map shows the geographic impact of Jonathan Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Parker more than expected).
Fields of papers citing papers by Jonathan Parker
This network shows the impact of papers produced by Jonathan Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Parker. The network helps show where Jonathan Parker may publish in the future.
Co-authorship network of co-authors of Jonathan Parker
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Parker. A scholar is included among the top collaborators of Jonathan Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Parker. Jonathan Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | QUANTITATIVE ANALYSIS OF SLIDE STEP DELIVERY IN HIGH SCHOOL BASEBALL PITCHERS | 0 |
| 6 | 4 | |
| 7 | 33 | |
| 8 | 27 | |
| 9 | Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. | 106 |
| 10 | Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. | 111 |
| 11 | 26 | |
| 12 | Proceedings: Echocardiography in infective endocarditis. | 7 |
About Jonathan Parker
Jonathan Parker is a scholar working on Developmental Biology, Biotechnology and Epidemiology, having authored 12 papers that have together received 329 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), Herpesvirus Infections and Treatments (3 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Rheumatology (67 citations), Rehabilitation (28 citations) and Epidemiology (130 citations). Jonathan Parker has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include John Darmawan, Peter J.F. Snijders, J. M. M. Walboomers, Renske D.M. Steenbergen, Louise T. Chow, Chris J.L.M. Meijer, Thomas R. Broker, Richard J. Whitley, G. Yancey Gillespie and James M. Markert. Their work appears in journals such as Journal of Clinical Oncology, Vaccine and American Journal of Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.